Swiss National Bank
CDTX

Swiss National Bank’s Cidara Therapeutics CDTX Stock Holding History

Swiss National Bank’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,500
Closed -$4.97M – 2313
2025
Q4 		$4.97M Sell
22,500
-200
-0.9% -$32.3K ﹤0.01% 1356
2025
Q3 		$2.17M Buy
+22,700
New +$1.45M ﹤0.01% 1819

Swiss National Bank's CDTX Position: Q1 2026 in Review

Swiss National Bank sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 22,500 shares — an estimated $4.97M sold.

Swiss National Bank first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $4.97M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

  • Swiss National Bank reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Swiss National Bank sold 22,500 Cidara Therapeutics shares in Q1 2026, an estimated $4.97M.
  • Swiss National Bank first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
  • Swiss National Bank's Cidara Therapeutics position peaked at $4.97M in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.